JPS54128573A - Cholestane derivative - Google Patents

Cholestane derivative

Info

Publication number
JPS54128573A
JPS54128573A JP2833979A JP2833979A JPS54128573A JP S54128573 A JPS54128573 A JP S54128573A JP 2833979 A JP2833979 A JP 2833979A JP 2833979 A JP2833979 A JP 2833979A JP S54128573 A JPS54128573 A JP S54128573A
Authority
JP
Japan
Prior art keywords
cholestane derivative
cholestane
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2833979A
Other languages
English (en)
Inventor
Barunaa Riharuto
Hiyuubushiyaa Yozefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS54128573A publication Critical patent/JPS54128573A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
JP2833979A 1978-03-15 1979-03-13 Cholestane derivative Pending JPS54128573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH281878 1978-03-15

Publications (1)

Publication Number Publication Date
JPS54128573A true JPS54128573A (en) 1979-10-05

Family

ID=4242270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2833979A Pending JPS54128573A (en) 1978-03-15 1979-03-13 Cholestane derivative

Country Status (5)

Country Link
US (1) US4204995A (ja)
EP (1) EP0004098B1 (ja)
JP (1) JPS54128573A (ja)
AT (1) AT367773B (ja)
DE (1) DE2962763D1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004307390A (ja) * 2003-04-07 2004-11-04 Mitsubishi Chemicals Corp ステロイド化合物の製造方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019059B1 (de) * 1979-05-18 1982-12-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholestenderivaten und neue Zwischenprodukte in deren Herstellung
CH644100A5 (de) * 1979-09-14 1984-07-13 Hoffmann La Roche Cholecalciferolderivate.
JPS5735599A (en) * 1980-08-05 1982-02-26 Chugai Pharmaceut Co Ltd 24,25-dihydroxycholestane and its preparation
EP0086350A3 (de) * 1982-02-12 1984-11-28 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholesterinderivaten
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
WO1997008336A1 (fr) * 1995-08-28 1997-03-06 Mercian Corporation Procede de production de cholesterols hydroxyles par conversion biologique et dihydroxycholesterols obtenus selon ce procede

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928397A (en) * 1973-03-02 1975-12-23 Eisai Co Ltd New 5-cholestene derivatives and preparation thereof
US4105660A (en) * 1977-06-29 1978-08-08 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5,7-dien-25-one
US4145346A (en) * 1977-10-03 1979-03-20 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004307390A (ja) * 2003-04-07 2004-11-04 Mitsubishi Chemicals Corp ステロイド化合物の製造方法

Also Published As

Publication number Publication date
EP0004098B1 (de) 1982-05-12
US4204995A (en) 1980-05-27
EP0004098A1 (de) 1979-09-19
DE2962763D1 (en) 1982-07-01
ATA191279A (de) 1981-12-15
AT367773B (de) 1982-07-26

Similar Documents

Publication Publication Date Title
GB2033893B (en) Tetrazolylalkoxycarbostyril derivatives
JPS54109975A (en) Thienohydantoin derivative
JPS54141798A (en) 44desacetyl vlboo33carboxyhydrazide derivative
JPS54119450A (en) 2hhbenzofurann33one derivative
JPS5589958A (en) Reelboss for tapeecassette
JPS54132627A (en) Cumalin derivative
JPS5527193A (en) Spiroofuranohydantoin derivative
GB2022079B (en) L-leucyl-4-hydroxyanilide derivatives
JPS54151966A (en) Nnsubstituted oxobenzothiazoline derivative
GB2018757B (en) 3-phenyltetrahydropyridine derivatives
JPS54128573A (en) Cholestane derivative
PH17055A (en) Delta4-androstenes derivative
GB2017708B (en) Steroid-spirooxazolidinone derivatives
JPS54128570A (en) Arylaminoimidazoline derivative
GB2017691B (en) 2-hydroxymethyl-pyrazine derivatives
GB2019843B (en) N-alkenylmoranoline derivatives
JPS5543080A (en) 22oxazolin derivative
GB2024806B (en) Onomycin derivatives
JPS54109991A (en) 111alkanoyll4***deoxyy4***isonitroooleandomycin derivative
JPS54163596A (en) Flonaphlizine derivative
GB2023574B (en) N-cyano-azomethine derivatives
GB2013187B (en) Phenylpyrol derivatives
JPS5581835A (en) Novel pentenee22yl derivative
JPS557262A (en) Novel bettaine derivative
JPS54154775A (en) Benzylpyrimidine derivative